PDE5A and pulmonary arterial hypertension: PDE5 inhibition is mostly known for its acute vasodilator effects on the coronary, systemic, and pulmonary vasculature [33,34], as well as its beneficial effects on pulmonary vascular remodeling in PAH [35].